The 22G>A polymorphism in the Adenosine deaminase gene impairs catalytic function but does not affect reactive hyperaemia in humans in vivo

Pharmacogenetics and Genomics

Volumn 18, Issue 10, 2008, Pages 843-846

  Riksen, Niels P ^a   Franke, Barbara ^a   Van Den Broek, Petra ^a   Naber, Marlies ^a   Smits, Paul ^a   Rongen, Gerard A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adenosine deaminase; Catalytic activity; Polymorphism; Reactive hyperaemia; Venous occlusion plethysmography

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE RECEPTOR;

ADULT; ARTICLE; CATALYSIS; CLINICAL ARTICLE; DEAMINATION; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN EXPERIMENT; HYPEREMIA; IN VIVO STUDY; ISCHEMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

ADENOSINE; ADENOSINE DEAMINASE; ADULT; CATALYSIS; ERYTHROCYTES; FEMALE; FOREARM; GENOTYPE; HUMANS; HYPEREMIA; KINETICS; MALE; POLYMORPHISM, GENETIC; TIME FACTORS; VASODILATOR AGENTS;

EID: 53549121154     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e328305e630     Document Type: Article

References (15)

1. Rongen GA, Roras JS, Lenders JW, Thien T, Smits P. Cardiovascular pharmacology of purines. Clin Sci 1997; 92:13-24.
2. Zhao ZQ, Nakanishi K, McGee DS, Tan P, Vmten-Johansen J. A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia. Cardiovasc Res 1994; 28:270-279.
3. Riksen NP, Franke B, Oyen WJ, Borm GF, van den Broek P, Boerman OC, et al. Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C>T variant of the AMPD1 gene. Eur Heart J 2007; 28:1085-1091.
4. Battistuzzi G, ludicone P, Santolamazza P, Petrucci R. Activity of adenosine deaminase allelic forms in intact erythrocytes and in lymphocytes. Ann Hum Genet 1981; 45:15-19.
5. Hirschhorn R, Yang DR, Israni A. An Asp8Asn substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA 2 allozyme): occurrence on different chromosomal backgrounds and apparent intragenic crossover. Ann Hum Genet 1994; 58:1-9.
6. Decking UK, Schlieper G, Kroll K, Schrader J. Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release. Circ Res 1997; 81:154-164.
7. Meijer P, Wouters CW, van den Broek PHH, Scheffer GJ, Riksen NP, Smits P, et al. Dipyridamole enhances ischaemia-induced reactive hyperaemia by increased adenosine receptor stimulation. Brit J Pharmacol 2008; 153:1169-1176.
8. Riksen NP, Franke B, van den BP, Smits P, Rongen GA. The 1976C>T polymorphism in the adenosine A2A receptor gene does not affect the vasodilator response to adenosine in humans in vivo. Pharmacogenet Genomics 2007; 17:551-554.
9. Riksen NP, Rongen GA, Boers GHJ, Blom HJ, van den Broek PHH, Smits P. Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 2005; 25:109-114.
10. Nestel PJ, Yamashita T, Sasahara T, Chin-Dusting JP, Esler MD, Dart AM, et al. Control of the forearm microcirculation: interactions with measures of obesity and noradrenaline kinetics. Clin Sci 1998; 95:203-212.
11. Anderson JL, Habashi J, Carlquist JF, Muhlestein JB, Home BD, Bair TL, et al. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. J Am Coll Cardiol 2000; 36:1248-1252.
12. Tang Z, Diamond MA, Chen JM, Holly TA, Bonow RO, Dasgupta A, et al. Polymorphisms in adenosine receptor genes are associated with infarct size in patients with ischemic cardiomyopathy. Clin Pharmacol Ther 2007; 82:435-440.
13. Willems L. Reichelt ME, Molina JG, Sun CX, Chunn JL, Ashton KJ, et al. Effects of adenosine deaminase and A(1) receptor deficiency in normoxic and ischaemic mouse hearts. Cardiovasc Res 2006; 71:79-87.
14. Peart J, Matherne GP, Cemiway RJ, Headrick JP. Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart. Cardiovasc Res 2001; 52:120-129.
15. Silva PH, Dillon D, Van Wylen DG. Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction. Cardiovasc Res 1995; 29:616-623